Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE Vernova Inc (GEV) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

GE Vernova IncTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

GE Vernova Inc vs Revolution Medicines Inc. Common Stock — how do they compare? GE Vernova Inc trades at $1,003.76 (market cap $266.16B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: GE Vernova Inc is far larger — about 6.6× Revolution Medicines Inc. Common Stock's market cap, and GE Vernova Inc pays a 0.2% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GE Vernova Inc for 36 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

GEVRVMD
Market Cap
$266.16B$40.32B
Volume
2,324,1654,855,734
Sector
IndustrialsHealth
52-Week High
$1.17K$221.15
52-Week Low
$547.96$47.50
Typical Hold Time
36 Days0 Days
Enterprise Value
$255.83B$37.02B
Dividend Yield
0.2%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE Vernova Inc

GE Vernova (GEV) trades at $1,004.73, up 0.77% with strong bullish technical momentum. The stock shows exceptional profitability with 23.04% net margins and 91.48% ROE, though valuation appears elevated with P/E of 28.65. Recent Q2 2026 earnings missed expectations, but Q1 and Q4 2025 results significantly beat forecasts. The company secured the first US construction permit for its BWRX-300 SMR, strengthening its nuclear pipeline amid growing AI-driven power demand.

Outlook remains positive with 75.86% analyst buy ratings and $1,270 consensus price target representing 26% upside. Key risks include execution challenges in wind segment and valuation concerns. Strong backlog growth to $176 billion and AI power demand create substantial growth runway, though investors should monitor margin expansion and competitive pressures.

Revolution Medicines Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEV
55% Buy45% Sell
Avg holding period · 36 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.

Read more on GEV →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →